60011-91-8Relevant academic research and scientific papers
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
-
, (2015/08/04)
The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds.
NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
-
, (2015/09/23)
The invention provides novel compounds having the general formula (I) wherein R1, R2 R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds in the treatment of the hepatitis B virus.
Synthesis, antitubulin, and antiproliferative sar of c3/c1-substituted tetrahydroisoquinolines
Dohle, Wolfgang,Leese, Mathew P.,Jourdan, Fabrice L.,Major, Meriel R.,Bai, Ruoli,Hamel, Ernest,Ferrandis, Eric,Kasprzyk, Philip G.,Fiore, Ann,Newman, Simon P.,Purohit, Atul,Potter, Barry V. L.
, p. 350 - 370 (2014/04/03)
The syntheses and antiproliferative activities of novel substituted tetrahydroisoquinoline derivatives and their sulfamates are discussed. Biasing of conformational populations through substitution on the tetrahydroisoquinoline core at C1 and C3 has a pro
Steroidomimetic tetrahydroisoquinolines for the design of new microtubule disruptors
Leese, Mathew P.,Jourdan, Fabrice,Dohle, Wolfgang,Kimberley, Meriel R.,Thomas, Mark P.,Bai, Ruoli,Hamel, Ernest,Ferrandis, Eric,Potter, Barry V. L.
, p. 5 - 9 (2012/04/04)
Structure-activity relationship translation offers an expeditious means for discovery of new active series. This approach was applied to discover tetrahydroisoquinoline (THIQ)-based steroidomimetic microtubule disruptors. The two A-ring elements of a thre
